A Kansas-based company launched a clinical trial in Colombia to reverse aging. But will it work?
There is an exciting new clinical trial launched in Columbia involving gene therapy to lengthen telomeres which are present on the end of each chromosome and prevent the deterioration of the DNA. Deterioration leads to aging and degenerative diseases such as cancer.
The trial has launched out of the reach of the American FDA which may not have approved this. Lengthening telomeres has been shown to reverse signs of aging in mice and individual human cells but never tried in humans until now.
The cost to enter the trial is $1,000,000 and it will be done on those aged 45 and over. With one group simply being aged individuals and another group with Alzheimer's disease and another group with critical limb ischemia.
Anti aging science is something I pay close attention to and hope to see aging eradicated so I shall be looking forward to seeing the results of this study and if telomerase therapy is likely going to be an option in the future.